The Emerging Short Chain Fatty Acid Enriched Metabotype in Irritable Bowel Syndrome and Its Potential Clinical Relevance.

Conley TE, Duncan A, Modasia A, Ford AC, Pritchard DM, Hildebrand F, Warren FJ, Spiller R, Probert CS. (2026)

Alimentary pharmacology & therapeutics

Metabolomic analysis in irritable bowel syndrome (IBS) has identified metabotypes enriched in faecal short-chain fatty acids (SCFAs), but it remains unclear whether this reflects rapid colonic transit or if these metabolites actively contribute to pathophysiology.

Alimentary pharmacology & therapeutics

View Publication